Liver disease is one of the most pressing, yet under-recognised, health challenges of our time. In the UK alone, liver disease is now the third

Metabolic dysfunction-associated steatotic liver disease should not be thought of as a niche hepatology problem. It is increasingly encountered across primary care, diabetes services, cardiology,

(London, UK) 10 September 2024. Following our recent announcement that hepatoSIGHT has received MHRA UKCA marking, we are excited to share that hepatoSIGHT has now also